What is renal atrophy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Renal Atrophy

Renal atrophy is defined as a reduction in kidney size with loss of renal parenchyma, characterized by tubular atrophy, interstitial fibrosis, and decreased cortical thickness, typically manifesting when kidney length falls below 9 cm or shows loss of corticomedullary differentiation. 1

Structural Characteristics

Size criteria:

  • Kidney length <7 cm indicates nonviable renal parenchyma 1
  • Kidney length between 7-9 cm suggests progressive atrophy 2
  • Average kidney length <14.5 cm with impaired function (serum creatinine ≥1.5 mg/dl) defines bilateral kidney atrophy in ADPKD 1

Cortical changes:

  • Loss of corticomedullary differentiation with absent or minimal cortex (<0.5 cm) indicates advanced atrophy 1
  • Cortical depressions overlying shrunken medullary pyramids with dilated calyces characterize segmental atrophy 3
  • Tubular atrophy with colloid-filled tubular microcysts and paucity or absence of glomeruli on histology 3

Pathophysiologic Features

Microscopic findings:

  • Tubular epithelial cell injury including apoptosis, proliferation, loss of differentiation, and atrophy 4
  • Interstitial fibrosis with increased and activated interstitial fibroblasts 4
  • Deposition of extracellular matrix proteins and loss of peritubular capillaries 4
  • Interstitial inflammatory cell infiltrates composed predominantly of macrophages and T cells 4

Functional correlates:

  • Renal function <10% of total renal function by scintigraphy indicates severe atrophy 2
  • Proteinuria (albumin-creatinine ratio >300 mg/g or protein-creatinine ratio >500 mg/g) may arise from atrophic kidney 1
  • Renal resistive index >0.8 suggests nonviable parenchyma 1

Common Etiologies

Vascular causes:

  • Longstanding renal artery stenosis with chronic ischemia is a major cause 1
  • Perinephric infiltration in conditions like Erdheim-Chester disease leads to progressive atrophy 1
  • Atherosclerotic renovascular disease with progressive stenosis 1

Obstructive causes:

  • Chronic urinary obstruction causing progressive tubular injury and interstitial fibrosis 4
  • Vesicoureteric reflux, particularly when associated with infection 3
  • Hydronephrosis from ureteral involvement 1

Other causes:

  • Chronic kidney disease with glomerulosclerosis, tubular atrophy, and interstitial fibrosis 1
  • Segmental atrophy (Ask-Upmark kidney) associated with reflux and hypertension 3
  • Acquired cystic disease in chronic kidney disease 1

Clinical Significance

Prognostic implications:

  • Tubular atrophy is superior to glomerular pathology as a predictor of GFR decline in CKD 5
  • Renal atrophy is associated with lesion severity and progression in renal artery stenosis 1
  • Left renal atrophy occurs more frequently (1.3%) than right (0.2%), possibly due to aortic pressure-induced flow disorders 6

Treatment considerations:

  • Kidneys <7 cm with <10% function and renin hypersecretion (ratio >1.5) may warrant nephrectomy for refractory hypertension 1, 2
  • Revascularization should be considered for high-grade stenosis with viable parenchyma (>8 cm length, cortex >0.5 cm) to prevent further atrophy 1
  • Relief of obstruction does not reverse established tubulointerstitial nephritis; lesions persist and progress even after obstruction is relieved 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Management of renal atrophy in hypertensive patients: experience in Lille].

Presse medicale (Paris, France : 1983), 2010

Research

Segmental "hypoplasia" of the kidney (Ask-Upmark).

The Journal of pediatrics, 1979

Research

Obstructive uropathy.

Contributions to nephrology, 2011

Research

Tubular atrophy in the pathogenesis of chronic kidney disease progression.

Pediatric nephrology (Berlin, Germany), 2016

Research

Left renal atrophy.

International journal of clinical and experimental medicine, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.